Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Accumulated Depreciation & AmortizationCost of RevenueEBIATLeasesMachine, Furnitures, Fixtures & OtherOther Gross PP&E AdjustmentsProperty, Plant & Equipment (Gross)Receivables - Net
Ratios

Krystal Biotech (KRYS) Other Gross PP&E Adjustments (2021 - 2025)

Krystal Biotech's Other Gross PP&E Adjustments history spans 5 years, with the latest figure at $168.9 million for Q4 2025.

  • For Q4 2025, Other Gross PP&E Adjustments changed 0.44% year-over-year to $168.9 million; the TTM value through Dec 2025 reached $168.9 million, changed 0.44%, while the annual FY2025 figure was $168.9 million, 0.44% changed from the prior year.
  • Other Gross PP&E Adjustments for Q4 2025 was $168.9 million at Krystal Biotech, up from $164.2 million in the prior quarter.
  • Across five years, Other Gross PP&E Adjustments topped out at $168.9 million in Q4 2025 and bottomed at $32.4 million in Q1 2021.
  • The 5-year median for Other Gross PP&E Adjustments is $160.6 million (2023), against an average of $140.3 million.
  • The largest annual shift saw Other Gross PP&E Adjustments skyrocketed 298.23% in 2022 before it decreased 2.07% in 2025.
  • A 5-year view of Other Gross PP&E Adjustments shows it stood at $107.3 million in 2021, then surged by 42.54% to $153.0 million in 2022, then grew by 4.31% to $159.6 million in 2023, then grew by 5.37% to $168.1 million in 2024, then grew by 0.44% to $168.9 million in 2025.
  • Per Business Quant, the three most recent readings for KRYS's Other Gross PP&E Adjustments are $168.9 million (Q4 2025), $164.2 million (Q3 2025), and $164.1 million (Q2 2025).